Terms: = Gastric cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Treatment
419 results:
1. Circular RNA CircSLC22A23 Promotes gastric cancer Progression by Activating HNRNPU Expression.
Wu X; Cao C; Li Z; Xie Y; Zhang S; Sun W; Guo J
Dig Dis Sci; 2024 Apr; 69(4):1200-1213. PubMed ID: 38400886
[TBL] [Abstract] [Full Text] [Related]
2. Elucidating molecular mechanisms and therapeutic synergy: irreversible HER2-TKI plus T-Dxd for enhanced anti-HER2 treatment of gastric cancer.
Liu J; Zhu T; Zhao R; Ren W; Zhao F; Liu J
Gastric Cancer; 2024 May; 27(3):495-505. PubMed ID: 38386239
[TBL] [Abstract] [Full Text] [Related]
3. Modified Chaishao Liujunzi Decoction inhibits bile acid-induced gastric intestinal metaplasia: from network prediction to experimental verification.
Sun Z; Liu Y; Deng H; Wang S; Zhang J; Xing C; Xu C
Aging (Albany NY); 2023 Dec; 15(23):13998-14018. PubMed ID: 38096029
[TBL] [Abstract] [Full Text] [Related]
4. The Future of HER2-Targeted treatment for Osteosarcoma: Lessons from the Negative Trastuzumab Deruxtecan Results.
Nakano K
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069146
[TBL] [Abstract] [Full Text] [Related]
5. Network pharmacology‑based investigation of potential targets of triptonodiol acting on non-small-cell lung cancer.
Jin F; Ni X; Yu S; Jiang X; Zhou J; Mao D; Liu Y; Wu F
Eur J Med Res; 2023 Nov; 28(1):547. PubMed ID: 38017514
[TBL] [Abstract] [Full Text] [Related]
6. Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line treatment of Advanced gastric cancer: K-Umbrella gastric cancer Study.
Lee CK; Kim HS; Jung M; Kim H; Bae WK; Koo DH; Jeung HC; Park SR; Hwang IG; Zang DY; Lee HW; Park S; Nam CM; Chung HC; Rha SY
J Clin Oncol; 2024 Jan; 42(3):348-357. PubMed ID: 37883723
[TBL] [Abstract] [Full Text] [Related]
7. [Mechanism of Astragali Radix-Curcumae Rhizoma in treating gastric cancer based on network pharmacology and experimental verification].
Tan XY; Tao J; Zhang Y; Gu RX
Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):5056-5067. PubMed ID: 37802848
[TBL] [Abstract] [Full Text] [Related]
8. Gancao Xiexin Decoction inhibits gastric carcinoma proliferation and migration by regulating the JAK2/STAT3 signalling pathway.
Yang Y; Yuan L; Meng F; Lu D; Che M; Zhou X; Chen G; Ning N; Nan Y
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117241. PubMed ID: 37777026
[TBL] [Abstract] [Full Text] [Related]
9. Network Pharmacology-Based Identification of Key Pharmacological Mechanism of Shen-qi-di-huang Decoction Acting on Uremia.
Zhang X; Chen XF; Chen WJ; Ding H; Zhang BX
Altern Ther Health Med; 2024 Jan; 30(1):44-50. PubMed ID: 37773677
[TBL] [Abstract] [Full Text] [Related]
10. Cardiorespiratory fitness and BMI measured in youth and 5-year mortality after site-specific cancer diagnoses in men-A population-based cohort study with register linkage.
Onerup A; Mehlig K; Ekblom-Bak E; Lissner L; Börjesson M; Åberg M
Cancer Med; 2023 Oct; 12(19):20000-20014. PubMed ID: 37732468
[TBL] [Abstract] [Full Text] [Related]
11. Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs.
Pace A; Scirocchi F; Napoletano C; Zizzari IG; Po A; Megiorni F; Asquino A; Pontecorvi P; Rahimi H; Marchese C; Ferretti E; Nuti M; Rughetti A
J Transl Med; 2023 Sep; 21(1):626. PubMed ID: 37715207
[TBL] [Abstract] [Full Text] [Related]
12. The disappearance of gastric metastasis and liver metastasis in non-small cell lung adenocarcinoma is due to osimertinib.
Wang Y; Yan C; Zhang C; Yu E; Wang K; Liu X; Yu J; Zhou C; Yang A
J Cancer Res Clin Oncol; 2023 Nov; 149(17):16069-16073. PubMed ID: 37695388
[TBL] [Abstract] [Full Text] [Related]
13. HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis.
Di Agostino S; Canu V; Donzelli S; Pulito C; Sacconi A; Ganci F; Valenti F; Goeman F; Scalera S; Rollo F; Bagnato A; Diodoro MG; Vizza E; Carosi M; Rufini B; Federici O; Giofrè M; Carboni F; Muti P; Ciliberto G; Strano S; Valle M; Blandino G
Cell Death Dis; 2023 Aug; 14(8):535. PubMed ID: 37598177
[TBL] [Abstract] [Full Text] [Related]
14. [Skip metastasis at the esophageal resection margin in radical gastrectomy: clinical characteristics of 30 cases].
Liu S; Xia QY; Fu Y; Lu XF; Wang M; Guan WX
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):675-679. PubMed ID: 37583025
[No Abstract] [Full Text] [Related]
15. The first Middle East and North Africa expert consensus recommendations for management of advanced gastric cancer.
Kourie HR; Mahrous M; Naim N; Zouein J; Benbrahim Z; Rasul K; Mokhtar M; Shehri AA; Shakeeb M; Khatib S; Al-Shamsi H; Shamseddine A; Smyth E
Future Oncol; 2023 Jul; 19(21):1451-1459. PubMed ID: 37526151
[TBL] [Abstract] [Full Text] [Related]
16. Exploring the Potential Mechanism of Action of Ursolic Acid against gastric cancer and COVID-19 using Network Pharmacology and Bioinformatics Analysis.
Liu Z; Huang H; Yu Y; Jia Y; Li L; Shi X; Wang F
Curr Pharm Des; 2023; 29(16):1274-1292. PubMed ID: 37218202
[TBL] [Abstract] [Full Text] [Related]
17. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
[TBL] [Abstract] [Full Text] [Related]
18. Pyrotinib alone or in combination with docetaxel in refractory HER2-positive gastric cancer: A dose-escalation phase I study.
Liu D; Kou F; Gong J; Wang Z; Zhang X; Li J; Li Y; Li J; Zhou J; Lu M; Wang X; Lu Z; Cao Y; Zou J; Zhu X; Xu R; Shen L
Cancer Med; 2023 May; 12(9):10704-10714. PubMed ID: 37081722
[TBL] [Abstract] [Full Text] [Related]
19. A multiparametric fluorescent visualization approach for detecting drug resistance in living cancer cells.
Zhou Z; Wang Y; Shao Z; Zhang G; Jiang H; Tang Y; Huang Z; Zhu Y; Li J
Talanta; 2023 Jul; 259():124564. PubMed ID: 37080074
[TBL] [Abstract] [Full Text] [Related]
20. Genetic and immune microenvironment characterization of HER2-positive gastric cancer: Their association with response to trastuzumab-based treatment.
Kwon HJ; Park Y; Nam SK; Kang E; Kim KK; Jeong I; Kwak Y; Yoon J; Kim TY; Lee KW; Oh DY; Im SA; Kong SH; Park DJ; Lee HJ; Kim HH; Yang HK; Lee HS
Cancer Med; 2023 May; 12(9):10371-10384. PubMed ID: 36916290
[TBL] [Abstract] [Full Text] [Related]
[Next]
